Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

US asks Roche for more information related to $5.7B hostile takeover bid for Illumina
Yahoo/AP
Wednesday, March 14, 2012 - 10:51am
tags:
Roche, Illumina, hostile bid, M&A
Sucampo Pharmaceuticals Increases Sales but Misses Estimates on Earnings
Motley Fool
Wednesday, March 14, 2012 - 10:49am
tags:
earnings, Sucampo
SciClone Q4 beats estimates, sees strong 2012
Reuters
Wednesday, March 14, 2012 - 10:47am
tags:
earnings, SciClone
Forest Labs May Soon Lose Its Independence: Options Play
Seeking Alpha
Wednesday, March 14, 2012 - 10:46am
tags:
Forest Labs, poison pill
Dendreon does not see choice between Provenge and Jevtana/Zytiga as 'either/or'
Yahoo/Fly on the Wall
Wednesday, March 14, 2012 - 10:45am
tags:
Dendreon, Provenge, Jevtana, Zytiga, prostate cancer
Elan to bank $381 million from sale of Alkermes stock
Pharma Times, UK
Wednesday, March 14, 2012 - 9:45am
tags:
Alkermes, Elan
Animal import bans "put UK drug research at risk"
Reuters
Wednesday, March 14, 2012 - 9:44am
tags:
United Kingdom, R&D
Former Merck Unit Works on First Vaccine for Hepatitis C
Bloomberg
Wednesday, March 14, 2012 - 9:43am
tags:
Merck, vaccines, hepatitis C, Okairos
A Drug Class Back From the Dead?
Motley Fool
Wednesday, March 14, 2012 - 9:42am
tags:
Pfizer, Regeneron, JNJ, Sanofi, AstraZeneca, FDA, NGF blockers
Anacor Pharma takes bigger 4Q loss on costs
Yahoo/AP
Wednesday, March 14, 2012 - 9:39am
tags:
earnings, Anacor
NicOx Shares Gain on Glaucoma Drug Study Results
Bloomberg Businessweek
Tuesday, March 13, 2012 - 12:02pm
tags:
glaucoma, NicOx, BOL-303259-X, Bausch & Lomb
Can Statins Prevent Parkinson's Disease?
Health Day
Tuesday, March 13, 2012 - 11:50am
tags:
statins, Parkinson's Disease
Verastem's Chances Are Slimmer Than Investment Banks Would Have You Think
Seeking Alpha
Tuesday, March 13, 2012 - 11:49am
tags:
Verastem, IPOs
Cornerstone Therapeutics says FDA begins review of treatment for low blood sodium levels
Yahoo/AP
Tuesday, March 13, 2012 - 11:47am
tags:
Cornerstone Therapeutics, FDA, low blood sodium, CRTX 80
Talon: Assessing Marqibo's FDA Odds
TheStreet.com
Tuesday, March 13, 2012 - 11:45am
tags:
Talon Therapeutics, Marqibo, FDA, leukemia
Omeros gains as eye drug meets late-stage trial goal
Reuters
Tuesday, March 13, 2012 - 11:44am
tags:
Omeros, OMS302
Galena Looks Undervalued Considering Cancer Therapy Results
Seeking Alpha
Tuesday, March 13, 2012 - 11:38am
tags:
Galena Biopharma, NeuVax
Allergan wins injunction against Botox alternative
Pharma Times, UK
Tuesday, March 13, 2012 - 11:29am
tags:
Botox, Allergan, Merz, Xeomin
FDA warns Warner Chilcott on Puerto Rico plant violations
Reuters
Tuesday, March 13, 2012 - 11:25am
tags:
FDA, Warner Chilcott, Puerto Rico, warnings, drug manufacturing
Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug
Seeking Alpha
Tuesday, March 13, 2012 - 11:25am
tags:
Cel-Sci, Teva Pharmaceuticals, Multikine, head and neck cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.